Gland Pharma

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue1,0631,103856.901,044938.29
Expenses742.25785.63621.61784.23686.33
EBITDA321.08317.38235.29260.17251.96
EBIT293.25286.30200.38223.50214.35
Profit Before Tax365.56380.48308.78324.08310.85
Net Profit273.03285.90229.45241.24231.95
Financial Ratios
Operating Profit Margin30.20%28.77%27.46%24.91%26.85%
Net Profit Margin25.68%25.92%26.78%23.10%24.72%
Earning Per Share (Diluted)16.6217.2413.9414.6514.08
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI